Epinephrine Auto-Injectors

• • Symjepi injection, Sandoz, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 00781-3442-20
  • Epinephrine injection, Amneal, 0.15 mg/0.15 mL, auto-injector, 2 count, NDC 00115-1695-49
  • Epinephrine injection, Amneal, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 00115-1694-49
  • Epinephrine injection, Teva, 0.15 mg/0.3 mL, auto-injector, 2 count, NDC 00093-5985-27
  • Epinephrine injection, Teva, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 00093-5986-27

• • Amneal has discontinued Adrenaclick. Amneal acquired Impax in 2018.
  • Mylan has epinephrine auto-injectors available.
  • Sandoz did not provide a reason for the shortage.
  • Teva did not provide a reason for the shortage.

• • Auvi-Q injection, Kaleo, 0.1 mg/0.1 mL, auto-injector, 2 count, NDC 60842-0021-01
  • Auvi-Q injection, Kaleo, 0.15 mg/0.15 mL, auto-injector, 2 count, NDC 60842-0022-01
  • Auvi-Q injection, Kaleo, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 60842-0023-01
  • EpiPen injection, Mylan, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 49502-0500-02
  • EpiPen Jr injection, Mylan, 0.15 mg/0.3 mL, auto-injector, 2 count, NDC 49502-0501-02
  • Epinephrine injection, Mylan, 0.15 mg/0.3 mL, auto-injector, 2 count, NDC 49502-0101-02
  • Epinephrine injection, Mylan, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 49502-0102-02

Estimated Resupply Dates

• • Amneal has epinephrine 0.15 mg/0.15 mL and 0.3 mg/0.3 mL auto-injectors on allocation.
  • Sandoz has Symjepi available with short expiration dating (November 2020 and March 2021).
  • Teva has epinephrine 0.15 mg/0.15 mL and 0.3 mg/0.3 mL auto-injectors on back order and the company estimates release dates in early-June 2020.

Safety

• • FDA has extended the expiration dating for certain lots of EpiPen and some generic epinephrine auto-injectors. https://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm563360.htm